Clinical Trials on Prostatic Disease
Total 380511 results
-
Rennes University HospitalCenter Eugene MarquisCompletedProstate Cancer | Prostate AdenocarcinomaFrance
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
University College London HospitalsCompleted
-
Tufts UniversityCompletedProstate NeoplasmUnited States
-
Albert DeNittisUnknown
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial Hospital; Chang Gung Memorial Hospital; Taipei Veterans... and other collaboratorsRecruiting
-
Dana MathewsCompletedProstate Cancer | Prostate Cancer MetastaticUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate Cancer PatientsUnited States
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedOligometastatic Prostate CancerSpain
-
Sun Pharmaceutical Industries LimitedCompleted
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
Portland VA Medical CenterNational Cancer Institute (NCI); OHSU Knight Cancer Institute; Oregon State UniversityCompletedProstate Cancer PreventionUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Institut Claudius RegaudCompleted
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Burzynski Research InstituteTerminatedMetastatic Prostate CancerUnited States
-
Astellas Pharma Europe Ltd.Terminated
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
SanofiCompletedProstate Cancer MetastaticIndia
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
DexTech Medical ABCompletedProstate Cancer MetastaticSweden
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
University of Turin, ItalyUnknownAdvanced Prostate CancerItaly
-
AstraZenecaCompletedAdvanced Prostate CancerCroatia
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminatedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Colorado, DenverEDAP TMS S.A.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States